http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10968430-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34756853592388da4d99a130d606d440
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-11
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9900c602536f35164c2776b345fcf198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07cff59e570c85141327a659581c08aa
publicationDate 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10968430-B2
titleOfInvention Use of specific regulatory T-cells to induce immune tolerance
abstract The present invention generally relates to the production of antigen-specific T regulatory cells (Tregs). Such cells can be used in therapy to minimize undesirable immune responses such as those observed in autoimmunity and hemophilia and other diseases as well as in the response to protein therapy for genetic diseases. Methods for producing antigen specific Tregs and conditions for preferential expansion of functionally stable, specific Tregs are also provided.
priorityDate 2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10093901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008095141-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003147865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070090-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002182670-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012027739-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02072796-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003152559-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23619366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524

Total number of triples: 41.